Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CED”

147 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 147 results

Early research (Phase 1)Study completedNCT04264143
What this trial is testing

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

Who this might be right for
Diffuse Intrinsic Pontine GliomaDiffuse Pontine and Thalamic GliomasDiffuse Midline Glioma
Luca Szalontay 9
Not applicableStudy completedNCT06604390
What this trial is testing

The EFFECTS of GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION on COGNITIVE FUNCTION, EXPRESSION of APP, MAPT, BDNF, IL-10, TGF-Β GENES, and PLASMA MDA LEVELS in the ELDERLY.

Who this might be right for
Elderly Individuals Aged 60 Years or OlderMild Cognitive Impairment (MCI)
Rahmi Novita Yusuf 64
Not applicableUnknownNCT04803162
What this trial is testing

The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

Who this might be right for
Eosinophilic Esophagitis
Wroclaw Medical University 58
Early research (Phase 1)Study completedNCT00923169
What this trial is testing

Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)

Who this might be right for
Renal Cell Carcinoma
National Cancer Institute (NCI) 9
Not applicableLooking for participantsNCT06058234
What this trial is testing

Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

Who this might be right for
Mild Alzheimer's DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Centers for Medicare and Medicaid Services/ Coverage and Analysis Group 8,680
Testing effectiveness (Phase 2)Active Not RecruitingNCT03264131
What this trial is testing

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Who this might be right for
LymphomaAdult T-Cell Leukemia/LymphomaLymphatic Diseases
UNC Lineberger Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT04812067
What this trial is testing

A Safety and Efficacy Trial of TTHX1114 in People With CED

Who this might be right for
Corneal Endothelial Dystrophy
Trefoil Therapeutics, Inc. 41
Post-approval studies (Phase 4)UnknownNCT01184599
What this trial is testing

A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAHypertension
Kagawa University 30
Very early researchWithdrawnNCT03193463
What this trial is testing

Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy

Who this might be right for
Glioma
Michael Vogelbaum, MD, PhD
Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Not applicableLooking for participantsNCT06626282
What this trial is testing

Fertility and Ovarian Reserve in Female Childhood Cancer Survivors

Who this might be right for
Childhood Cancer SurvivorsFertilityOvarian Reserve+5 more
Centre Hospitalier Universitaire de Liege 340
Not applicableStudy completedNCT04614571
What this trial is testing

T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge

Who this might be right for
Celiac Disease
Regeneron Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Early research (Phase 1)Active Not RecruitingNCT00368082
What this trial is testing

Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

Who this might be right for
LymphomaHodgkin's DiseaseRelapse+1 more
Baylor College of Medicine 8
Testing effectiveness (Phase 2)WithdrawnNCT03470350
What this trial is testing

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
The Netherlands Cancer Institute
Early research (Phase 1)Study completedNCT02734160
What this trial is testing

Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Eli Lilly and Company 37
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Not applicableStudy completedNCT05988476
What this trial is testing

Investıgatıon of The Effıciency of Pulsed Electromagnetıc Field Therapy and Stretching Exercises

Who this might be right for
Muscle InjuryPulsed Electromagnetic TherapyMuscle Stretching Exercise
Suleyman Demirel University 64
Early research (Phase 1)Study completedNCT02022644
What this trial is testing

Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

Who this might be right for
High Grade Glioma
University of California, San Francisco 18
Testing effectiveness (Phase 2)Ended earlyNCT04212650
What this trial is testing

Losartan to Improve Hip Microfracture

Who this might be right for
Hip OsteoarthritisHip Impingement SyndromeCartilage Damage+1 more
Steadman Philippon Research Institute 1
Load More Results